CDKN2D (p19INK4D)
E1553935
UNEXPLORED
CDKN2D (p19INK4D) is a cyclin-dependent kinase inhibitor that helps control cell cycle progression by inhibiting CDK4/6 activity and acting as a tumor suppressor.
All labels observed (1)
| Label | Occurrences |
|---|---|
| CDKN2D (p19INK4D) canonical | 1 |
How this entity was disambiguated
This entity first appeared as the object of triple T22690299 — resolving that mention is where its identity was fixed. The disambiguator weighed these candidate entities and picked the highlighted one (or “None”, minting a new entity). This is how homonymy is resolved: the same surface form can point to different entities.
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: CDKN2D (p19INK4D) Context triple: [CDK4, regulatedBy, CDKN2D (p19INK4D)]
-
A.
CDKN2C (p18INK4C)
CDKN2C (p18INK4C) is a cyclin-dependent kinase inhibitor that helps control cell cycle progression by inhibiting CDK4/6 activity and acting as a tumor suppressor.
-
B.
CDKN2B (p15INK4B)
CDKN2B (p15INK4B) is a cyclin-dependent kinase inhibitor tumor suppressor protein that controls cell cycle progression by inhibiting CDK4/6 activity.
-
C.
CDKN2A (p16INK4A)
CDKN2A (p16INK4A) is a tumor suppressor gene encoding a cyclin-dependent kinase inhibitor that controls cell cycle progression and is frequently inactivated in human cancers.
-
D.
CDK4
CDK4 is a cyclin-dependent kinase that regulates cell cycle progression and is a key therapeutic target in certain cancers.
-
E.
cyclin D2
Cyclin D2 is a regulatory protein that controls progression through the G1 phase of the cell cycle by activating cyclin-dependent kinases involved in cell proliferation.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: CDKN2D (p19INK4D) Target entity description: CDKN2D (p19INK4D) is a cyclin-dependent kinase inhibitor that helps control cell cycle progression by inhibiting CDK4/6 activity and acting as a tumor suppressor.
-
A.
CDKN2C (p18INK4C)
CDKN2C (p18INK4C) is a cyclin-dependent kinase inhibitor that helps control cell cycle progression by inhibiting CDK4/6 activity and acting as a tumor suppressor.
-
B.
CDKN2B (p15INK4B)
CDKN2B (p15INK4B) is a cyclin-dependent kinase inhibitor tumor suppressor protein that controls cell cycle progression by inhibiting CDK4/6 activity.
-
C.
CDKN2A (p16INK4A)
CDKN2A (p16INK4A) is a tumor suppressor gene encoding a cyclin-dependent kinase inhibitor that controls cell cycle progression and is frequently inactivated in human cancers.
-
D.
CDK4
CDK4 is a cyclin-dependent kinase that regulates cell cycle progression and is a key therapeutic target in certain cancers.
-
E.
cyclin D2
Cyclin D2 is a regulatory protein that controls progression through the G1 phase of the cell cycle by activating cyclin-dependent kinases involved in cell proliferation.
- F. None of above. chosen
Referenced by (1)
Full triples — surface form annotated when it differs from this entity's canonical label.